2'3'-cGAMP (sodium salt): Precision Tool for STING-Mediated Innate Immunity Research

Executive Summary: 2'3'-cGAMP (sodium salt) is a cyclic dinucleotide produced by cGAS upon sensing cytosolic double-stranded DNA in mammalian cells, acting as a second messenger in innate immunity. It directly binds and activates the STING protein with nanomolar affinity (Kd = 3.79 nM), a potency that is higher than other cyclic dinucleotides (Zhang et al., 2025). This activation triggers TBK1 and IRF3 phosphorylation, leading to robust type I interferon (IFN-β) induction. 2'3'-cGAMP (sodium salt) is water-soluble, chemically defined, and stable under frozen conditions, making it a preferred reagent for immunology, cancer, and antiviral research (product page). Recent studies highlight its unique capacity to normalize tumor vasculature and drive CD8+ T cell infiltration via endothelial STING-JAK1 signaling (Zhang et al., 2025).

Biological Rationale

2'3'-cGAMP (sodium salt) is the endogenous ligand for the Stimulator of Interferon Genes (STING) pathway. Mammalian cGAS catalyzes the synthesis of 2'3'-cGAMP upon sensing double-stranded DNA in the cytosol. This pathway acts as a central sensor of pathogen- and damage-associated molecular patterns, coupling cytosolic DNA detection to the induction of innate immune responses (Zhang et al., 2025).

Type I interferon (IFN-I) induction via STING activation is essential for antiviral defense, antitumor immunity, and the development of immunotherapeutic interventions. The robust, direct activation of STING by 2'3'-cGAMP is critical for dissecting this pathway in both basic and translational research. Compared to bacterial cyclic dinucleotides, 2'3'-cGAMP exhibits higher affinity and specificity for mammalian STING (product page).

Mechanism of Action of 2'3'-cGAMP (sodium salt)

Upon cytosolic double-stranded DNA detection, cGAS synthesizes 2'3'-cGAMP, which acts as a second messenger. 2'3'-cGAMP (sodium salt) binds the cyclic dinucleotide binding domain (CBD) of STING located on the endoplasmic reticulum membrane. This binding triggers a conformational change in STING, leading to its translocation to the Golgi apparatus (Zhang et al., 2025).

STING subsequently recruits and activates TANK-binding kinase 1 (TBK1), which phosphorylates interferon regulatory factor 3 (IRF3). Phosphorylated IRF3 translocates to the nucleus and induces transcription of type I interferon genes (e.g., IFN-β). STING activation also induces NF-κB signaling and inflammatory gene expression. Notably, endothelial STING activation promotes vessel normalization and CD8+ T cell infiltration in tumors, implicating cGAMP in tumor microenvironment modulation (Zhang et al., 2025).

Evidence & Benchmarks

• 2'3'-cGAMP (sodium salt) binds human STING with a Kd of 3.79 nM, outperforming bacterial CDNs (https://www.apexbt.com/2-3-cgamp-sodium-salt.html).
• Intratumoral 2'3'-cGAMP administration normalizes tumor vasculature and boosts CD8+ T cell infiltration in preclinical models (Zhang et al., 2025).
• STING agonism with 2'3'-cGAMP is required for endothelial JAK1 activation and IFN-I-mediated antitumor effects (Zhang et al., 2025).
• Palmitoylation at cysteine 91 of STING is essential for JAK1-STING interaction and downstream signaling (Zhang et al., 2025).
• 2'3'-cGAMP (sodium salt) is water-soluble at ≥7.56 mg/mL, but insoluble in ethanol or DMSO (https://www.apexbt.com/2-3-cgamp-sodium-salt.html).
• For optimal shelf-life, storage at -20°C is recommended (https://www.apexbt.com/2-3-cgamp-sodium-salt.html).

Applications, Limits & Misconceptions

2'3'-cGAMP (sodium salt) is used as a reference STING agonist in cellular, ex vivo, and in vivo models. Key applications include:

• Dissecting cGAS-STING signaling mechanisms in immune and endothelial cells.
• Evaluating innate immune responses and screening for STING-targeted therapeutics.
• Modeling tumor microenvironment remodeling and CD8+ T cell infiltration in cancer research.
• Probing antiviral innate immunity and type I interferon induction.
• Validating the functional relevance of STING pathway components (e.g., palmitoylation, JAK1 interaction).

This article extends the mechanistic focus of "2'3'-cGAMP (sodium salt): Mechanisms and Methodologies for cGAS-STING Signaling" by integrating new evidence on endothelial-specific STING-JAK1 crosstalk, and clarifies translational benchmarks for immunotherapy workflows.

For a translational roadmap, see "Unlocking Translational Potential: Strategic Deployment of 2'3'-cGAMP (sodium salt)", which this article updates with new mechanistic data on endothelial STING signaling.

Common Pitfalls or Misconceptions

• Does not activate non-STING pathways: 2'3'-cGAMP (sodium salt) specifically targets STING and does not robustly agonize other innate immune sensors.
• Species specificity: Murine and human STING differ in CDN binding; assay validation in the target species is critical.
• Solvent limitations: Insoluble in ethanol and DMSO; improper dissolution can lead to precipitation and reduced efficacy.
• Temperature instability: Storage above -20°C can result in hydrolysis or loss of bioactivity.
• Chronic activation risks: Prolonged or systemic administration may induce chronic inflammation or immune exhaustion (Zhang et al., 2025).

Workflow Integration & Parameters

For in vitro studies, 2'3'-cGAMP (sodium salt) should be dissolved in molecular biology-grade water at concentrations ≥7.56 mg/mL. For cell-based assays, titrate doses to match target cell type sensitivity; typical working concentrations range from 1 nM to 10 μM. For in vivo use, freshly prepare solutions in sterile saline, administer via direct injection, and monitor temperature stability. Store powder at -20°C in a desiccated environment for maximum stability (B8362 kit).

For advanced workflow recommendations, see "Unleashing the Potential of 2'3'-cGAMP (Sodium Salt): Strategic Parameters for Experimental Immunotherapy", which this article updates by integrating endothelial STING-JAK1 benchmarks.

Conclusion & Outlook

2'3'-cGAMP (sodium salt) remains the reference STING agonist for probing cGAS-STING signaling, benchmarking immunotherapeutic interventions, and dissecting type I interferon biology. Its high-affinity, water-solubility, and chemical stability underpin its preferred status in immunology research. Current evidence underscores its unique role in normalizing tumor vasculature and enhancing CD8+ T cell infiltration via endothelial-specific mechanisms. Ongoing research aims to optimize dosing, minimize off-target effects, and translate these findings into first-in-class cancer immunotherapies (Zhang et al., 2025).